Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Abelcet approved for marketing in Portugal

May 24, 1996

Antifungal antibiotic YM-47522 isolated by Yamanouchi

May 24, 1996

L-749345 in clinical trials at Merck & Co.

May 24, 1996

AmBisome approved in India

May 17, 1996

HNK20 moves to phase III

May 17, 1996

CMV NeutraGAM development update

May 17, 1996

Interferon Sciences reacquires U.S. and Canadian marketing rights for interferon product

May 17, 1996

IDEC receives NIAID grant to develop MAbs for RSV

May 17, 1996

Nippon Shoji to collaborate on nisin development in Pacific rim countries

May 17, 1996

Triazole antifungals reported by Tanabe

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...